These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36786124)

  • 21. What do people with intellectual disabilities, their family members and paid carers understand about psychotropic medication? A rapid review.
    Cavanagh DE; Caton S; Rawles J; Runswick-Cole K; Hatton C; Chauhan U; Hutchinson C
    J Appl Res Intellect Disabil; 2024 Sep; 37(5):e13283. PubMed ID: 39039824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of the use of psychotropic medication to address challenging behaviour in neurodevelopmental disorders.
    Valdovinos MG; Epperson C; Johnson C
    Int Rev Neurobiol; 2023; 173():43-65. PubMed ID: 37993179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study.
    Henderson A; Mcskimming P; Kinnear D; McCowan C; McIntosh A; Allan L; Cooper SA
    BMJ Open; 2020 Sep; 10(9):e036862. PubMed ID: 32912946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Psychotropic Prescribing Practices for Children and Adolescents with Intellectual Disabilities: A Cohort Study Using a Large-scale Health Insurance Database].
    Inoue Y; Okumura Y; Fujita J
    Seishin Shinkeigaku Zasshi; 2016; 118(11):823-833. PubMed ID: 30620838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
    Lunsky Y; Modi M
    Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
    Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors.
    García-Domínguez L; Navas P; Verdugo MÁ; Arias VB; Gómez LE
    J Appl Res Intellect Disabil; 2022 Sep; 35(5):1109-1118. PubMed ID: 35384179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsychotic and antidepressant prescribing for 704 297 children and young people with and without intellectual disabilities: record linkage study.
    Henderson A; Kinnear D; Fleming M; Stanley B; Greenlaw N; Young-Southward G; Pell JP; Cooper SA
    Br J Psychiatry; 2021 Jan; 218(1):58-62. PubMed ID: 33541472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Exploratory Study among Intellectual Disability Physicians on the Care and Coercion Act and the Use of Psychotropic Drugs for Challenging Behaviour.
    Bij de Weg JC; Honingh AK; Teeuw M; Sterkenburg PS
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structured Medication Review to Improve Pharmacotherapy in People with Intellectual Disability and Behavioural Problems.
    Scheifes A; Egberts TC; Stolker JJ; Nijman HL; Heerdink ER
    J Appl Res Intellect Disabil; 2016 Jul; 29(4):346-55. PubMed ID: 25882186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Use of Psychotropic Medication in Iranian Children with Developmental Disabilities.
    McConkey R; Samadi SA; Mahmoodizadeh A; Taggart L
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33924699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative Care for Challenging Behaviors in People with Intellectual Disabilities to Reduce Challenging Behaviors and Inappropriate Psychotropic Drug Prescribing Compared with Care as Usual: A Cluster-Randomized Trial.
    de Kuijper G; Jonker J; Kouwer K; Hoekstra PJ; de Bildt A
    Int J Environ Res Public Health; 2024 Jul; 21(7):. PubMed ID: 39063526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of psychotropic medication in people with a learning disability.
    Jenkins R
    Br J Nurs; 2000 Jul 13-26; 9(13):844-50. PubMed ID: 11261057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey.
    Perry BI; Cooray SE; Mendis J; Purandare K; Wijeratne A; Manjubhashini S; Dasari M; Esan F; Gunaratna I; Naseem RA; Hoare S; Chester V; Roy A; Devapriam J; Alexander R; Kwok HF
    J Intellect Disabil Res; 2018 Feb; 62(2):140-149. PubMed ID: 29349928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychotropic medication and psychotherapeutic treatment of adults with intellectual disabilities (PROMPT-ID): a cross-sectional, epidemiological study in Saxony, Germany.
    Koch A; Dobrindt J; Schützwohl M
    BMJ Open; 2018 Dec; 8(12):e025947. PubMed ID: 30573492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication use among Australian adults with intellectual disability in primary healthcare settings: a cross-sectional study.
    Doan TN; Lennox NG; Taylor-Gomez M; Ware RS
    J Intellect Dev Disabil; 2013 Jun; 38(2):177-81. PubMed ID: 23550741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of psychotropic medication and factors associated with antipsychotic treatment in adults with intellectual disabilities: a cross-sectional, epidemiological study in Germany.
    Koch AD; Dobrindt J; Schützwohl M
    J Intellect Disabil Res; 2021 Feb; 65(2):186-198. PubMed ID: 33393123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical restraint of adults with intellectual disability and challenging behaviour in Queensland, Australia: Views of statutory decision makers.
    Edwards N; King J; Williams K; Hair S
    J Intellect Disabil; 2020 Jun; 24(2):194-211. PubMed ID: 29929418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PRN usage before and after discharge from a forensic inpatient unit: A series example of patients with intellectual disabilities.
    Busch L; Saini V; Budin R; Jones RM
    J Appl Res Intellect Disabil; 2023 Mar; 36(2):405-410. PubMed ID: 36419217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.